Corinne Levy

Summary

Country: France

Publications

  1. ncbi [How pediatricians and GP consider the implementation of meningococal B vaccination in France?]
    R Cohen
    ACTIV Association Clinique et Thérapeutique Infantile du Val de Marne, 94100 Saint Maur des Fossés, France
    Arch Pediatr 19:1379-85. 2012
  2. ncbi [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results]
    C Levy
    GPIP Groupe de Pathologie Infectieuse Pédiatrique de la SFP Société Française de Pédiatrie, France
    Arch Pediatr 19:S49-54. 2012
  3. ncbi [Nasopharyngeal carriage of children 6 to 60 months during the implementation of the 13-valent pneumococcal conjugate vaccine]
    R Cohen
    Association Clinique et Thérapeutique Infantile du Val de Marne ACTIV, 27, rue Inkermann, 94100 Saint Maur des Fossés, France
    Arch Pediatr 19:1132-9. 2012
  4. ncbi PneumococcaL meningitis in french children before and after the introduction of pneumococcal conjugate vaccine
    Corinne Levy
    GPIP Groupe de Pathologie Infectieuse Pe diatrique de la SFP Socie te Franc aise de Pe diatrie, Paris, France
    Pediatr Infect Dis J 30:168-70. 2011
  5. ncbi [Impact of the rapid diagnosis downtown in the assumption of responsibility of the children in period of influenza]
    R Cohen
    Service de Microbiologie, Centre Hospitalier Intercommunal de Creteil, 40, avenue de Verdun, 94000 Creteil, France
    Arch Pediatr 14:926-31. 2007
  6. ncbi [Influenza rapid diagnostic tests: are they beneficial in the pediatric emergency department or in ambulatory pediatrics?]
    F de La Rocque
    ACTIV Association Clinique et Thérapeutique Infantile du Val de Marne, 27, rue d Inkermann, 94100 Saint Maur des Fossés, France
    Arch Pediatr 14:532-3. 2007
  7. ncbi [Pediatric infections network]
    R Cohen
    ACTIV, 27, rue Inkermann, , France
    Arch Pediatr 13:634-5. 2006
  8. ncbi [French paediatrician and general practitioner's survey about actual and future BCG use]
    F de La Rocque
    Association Clinique et Thérapeutique Infantile du Val de Marne ACTIV, 27, rue d Inkermann, 94100 Saint Maur des Fossés, France
    Arch Pediatr 12:1665-9. 2005
  9. ncbi Variables influencing bacteriological outcome in patients with streptococcal tonsillopharyngitis treated with penicillin V
    Philippe Ovetchkine
    Department of Paediatrics, Créteil Hospital, Paris, France
    Eur J Pediatr 161:365-7. 2002
  10. ncbi Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination
    Robert Cohen
    Department of Microbiology, CHI Creteil, France
    BMC Infect Dis 11:95. 2011

Collaborators

Detail Information

Publications26

  1. ncbi [How pediatricians and GP consider the implementation of meningococal B vaccination in France?]
    R Cohen
    ACTIV Association Clinique et Thérapeutique Infantile du Val de Marne, 94100 Saint Maur des Fossés, France
    Arch Pediatr 19:1379-85. 2012
    ..To assess the acceptability of a vaccine against meningococcus B by pediatricians and GP and to analyze how the vaccine could be implemented in France, InfoVac-France has set up a national survey...
  2. ncbi [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results]
    C Levy
    GPIP Groupe de Pathologie Infectieuse Pédiatrique de la SFP Société Française de Pédiatrie, France
    Arch Pediatr 19:S49-54. 2012
    ....
  3. ncbi [Nasopharyngeal carriage of children 6 to 60 months during the implementation of the 13-valent pneumococcal conjugate vaccine]
    R Cohen
    Association Clinique et Thérapeutique Infantile du Val de Marne ACTIV, 27, rue Inkermann, 94100 Saint Maur des Fossés, France
    Arch Pediatr 19:1132-9. 2012
    ..Moreover, during the study period, the 13-valent pneumococcal conjugate vaccine (PCV13) has replaced PCV7 in June 2010...
  4. ncbi PneumococcaL meningitis in french children before and after the introduction of pneumococcal conjugate vaccine
    Corinne Levy
    GPIP Groupe de Pathologie Infectieuse Pe diatrique de la SFP Socie te Franc aise de Pe diatrie, Paris, France
    Pediatr Infect Dis J 30:168-70. 2011
    ..3 (median 0.8) to 3.8 (median 1.5) years. After pneumococcal conjugate vaccine 7 implementation, a wide diversity of serotypes implicated in pneumococcalmeningitis was observed; serotypes 19A and 7F were the most frequent...
  5. ncbi [Impact of the rapid diagnosis downtown in the assumption of responsibility of the children in period of influenza]
    R Cohen
    Service de Microbiologie, Centre Hospitalier Intercommunal de Creteil, 40, avenue de Verdun, 94000 Creteil, France
    Arch Pediatr 14:926-31. 2007
    ..0003). This study confirms the difficulty of clinical diagnosis, and shows the interest of IRDT for the diagnosis of influenza and consequently to improve the management of influenza in children in ambulatory paediatric setting...
  6. ncbi [Influenza rapid diagnostic tests: are they beneficial in the pediatric emergency department or in ambulatory pediatrics?]
    F de La Rocque
    ACTIV Association Clinique et Thérapeutique Infantile du Val de Marne, 27, rue d Inkermann, 94100 Saint Maur des Fossés, France
    Arch Pediatr 14:532-3. 2007
  7. ncbi [Pediatric infections network]
    R Cohen
    ACTIV, 27, rue Inkermann, , France
    Arch Pediatr 13:634-5. 2006
  8. ncbi [French paediatrician and general practitioner's survey about actual and future BCG use]
    F de La Rocque
    Association Clinique et Thérapeutique Infantile du Val de Marne ACTIV, 27, rue d Inkermann, 94100 Saint Maur des Fossés, France
    Arch Pediatr 12:1665-9. 2005
    ..6%). It seems not acceptable for 2/3 of physicians to address their patients to colleagues or to specialized structures...
  9. ncbi Variables influencing bacteriological outcome in patients with streptococcal tonsillopharyngitis treated with penicillin V
    Philippe Ovetchkine
    Department of Paediatrics, Créteil Hospital, Paris, France
    Eur J Pediatr 161:365-7. 2002
    ..This may lead to different antibiotic regimens and follow-up modalities for these targeted patients...
  10. ncbi Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination
    Robert Cohen
    Department of Microbiology, CHI Creteil, France
    BMC Infect Dis 11:95. 2011
    ..To determine factors potentially related to 19A nasopharyngeal (NP) carriage we analyzed data from an ongoing prospective French national surveillance study of pneumococcal NP carriage in young children...
  11. ncbi Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media
    Robert Cohen
    Service de Microbiologie, Centre Hospitalier Intercommunal de Creteil, Creteil, France
    Pediatr Infect Dis J 25:1001-7. 2006
    ..The implementation of widespread vaccination with the heptavalent pneumococcal conjugate vaccine (PCV7) and the reduction of inappropriate antibiotic use could help reduce antibiotic resistance...
  12. ncbi Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France
    Robert Cohen
    ACTIV, Association Clinique Thérapeutique Infantile du Val de Marne, 27 rue Inkermann, F94100 Saint Maur des Fossés, France
    BMC Infect Dis 12:52. 2012
    ..We aimed to compare the NP carriage rates in young children with acute otitis media (AOM) before and after PCV7 implementation in France...
  13. ncbi Decline in macrolide-resistant Streptococcus pyogenes isolates from French children
    Camille d'Humières
    Laboratoire d études de génétique bactérienne dans les infections de l enfant EA3105, Universite Denis Diderot Paris 7, Service de Microbiologie, Hopital Robert Debre, 75019 Paris, France
    Int J Med Microbiol 302:300-3. 2012
    ..6% erm(B). The 19 isolates included 7 different emm types (4, 1, 11, 2, 28, 12, and 77) and 7 corresponding multilocus sequence types. The current fall in macrolide consumption has led to a very low rate of GAS macrolide resistance...
  14. ncbi Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media
    Robert Cohen
    ACTIV Association Clinique et Thérapeutique Infantile du Val de Marne, Paris, France
    Pediatr Infect Dis J 31:297-301. 2012
    ..This program was used in 2010-2011 to assess the effect of the implementation of PCV13 on PNP carriage in young children with AOM...
  15. ncbi Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children
    Corinne Levy
    Groupe de Pathologie Infectieuse Pédiatrique, Société Française de Pédiatrie, Paris, France
    Pediatr Infect Dis J 29:618-23. 2010
    ....
  16. ncbi Pneumococcal conjugate vaccine does not influence Staphylococcus aureus carriage in young children with acute otitis media
    Robert Cohen
    Service de Microbiologie, Centre Hospitalier Intercommunal de Creteil, Creteil, France
    Clin Infect Dis 45:1583-7. 2007
    ..8.7% in nonvaccinated children). Furthermore, in children aged >1 year, the booster dose induces a sharp reduction in the carriage of vaccine serotypes of S. pneumoniae, without any change in S. aureus carriage...
  17. ncbi Spectrum and inoculum size effect of a rapid antigen detection test for group A streptococcus in children with pharyngitis
    Jérémie F Cohen
    Unité de Recherche Epidémiologique en Santé Périnatale et Santé des Femmes et des Enfants U953, INSERM, Paris, France
    PLoS ONE 7:e39085. 2012
    ..We aimed to assess whether the performance of a rapid antigen detection test (RADT) for group A streptococcus (GAS) is affected by the clinical spectrum and/or bacterial inoculum size...
  18. ncbi Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal Vaccination for French children
    Farah Mahjoub-Messai
    Service de Microbiologie, Hôpital Robert Debré APHP, 75019 Paris, France
    J Clin Microbiol 47:837-40. 2009
    ..By applying multilocus sequence typing to 144 serotype 19A isolates collected before and after beginning PCV7 vaccination, we detected clonal expansion of the preexisting penicillin-intermediate sequence type 276...
  19. ncbi Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis
    Robert Cohen
    Association Clinique et Thérapeutique Infantile du Val de Marne, Paris, France
    Pediatr Infect Dis J 21:297-303. 2002
    ..This study investigates the efficacy and tolerability of two dosages of 3-day azithromycin (20 mg/kg/day and 10 mg/kg/day) compared with 10-day penicillin V...
  20. ncbi Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levels
    Vincent Couloigner
    Service d ORL Pédiatrique, Necker Hospital, AP HP, Universite Paris 5, Paris, France
    Pediatr Infect Dis J 31:154-8. 2012
    ..The causative pathogens were Streptococcus pneumoniae (Sp) followed by nontypable Haemophilus influenzae (NTHi). The aim of this study was to describe the epidemiology of pathogens involved in AOM treatment failures or recurrences...
  21. ncbi Sensitivity of the bacterial meningitis score in 889 children with bacterial meningitis
    Francois Dubos
    Clinical Epidemiology Unit, Department of Pediatrics, Saint Vincent de Paul Hospital, AP HP and Paris Descartes University, Paris, France
    J Pediatr 152:378-82. 2008
    ..To validate sensitivity of the bacterial meningitis score (BMS) in a large population of children with bacterial meningitis (BM)...
  22. ncbi Bacterial meningitis in children: a French prospective study
    Edouard Bingen
    Service de Microbiologie EA3105, Hopital Robert Debre, Paris, France
    Clin Infect Dis 41:1059-63. 2005
    ..7%). Approximately one-half of S. pneumoniae isolates had diminished susceptibility to penicillin. The case-fatality rates were 7.6% for children with N. meningitidis meningitis and 10.8% for children with S. pneumoniae infection...
  23. ncbi Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in French children
    André Birgy
    Laboratoire associé au Centre National de Référence Escherichia coli et Shigelles, Service de Microbiologie, Hôpital Robert Debré AP HP, Universite Denis Diderot, Sorbonne, Paris Cité, Paris, F 75505, France
    BMC Infect Dis 12:315. 2012
    ..Because intestinal carriage is a key factor in the epidemiology of ESBL-producing Enterobacteriaceae, the study of the prevalence of these resistant bacteria and risk factors in young children is of particular interest...
  24. ncbi Evaluation of a model for efficient screening of tuberculosis contact subjects
    Khaoula Aissa
    Service de Pediatrie, Centre Hospitalier Intercommunal de Creteil, Creteil, France
    Am J Respir Crit Care Med 177:1041-7. 2008
    ..Contact tracing is an important component of tuberculosis (TB) control programs. Standardization of contact investigation protocols can make them more efficient...
  25. ncbi Corticosteroid Therapy in Genotype ST-11 Meningococcal Infections
    Fouad Madhi
    From the Service de Pédiatrie, Centre Hospitalier Intercommunal Inserm U955, Equipe 11, Faculte de Medecine, Universite Paris Est, Créteil GPIP Groupe de Pathologie Infectieuse Pédiatrique, SFP Société Française de Pédiatrie Association Clinique et Thérapeutique Infantile du Val de Marne ACTIV, Paris CRC CHI, Créteil and Institut Pasteur, Invasive Bacterial Infections Unit, National Reference Center for Meningococci, Paris, France
    Pediatr Infect Dis J 32:291-3. 2013
    ..Genotypes of meningococcal isolates should be considered with corticosteroids therapy for meningococcal disease...
  26. ncbi Hospitalization of newborns and young infants for chickenpox in France
    Aurélie Lécuyer
    Association Clinique et Thérapeutique Infantile du Val de Marne ACTIV, Saint Maur des Fossés, France
    Eur J Pediatr 169:1293-7. 2010
    ..Unless the absence of maternal VZV immunity is demonstrated, newborns with mild chickenpox should not require antiviral therapy...